21.09

0.11% 0.02

Innoviva Inc (INVA)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Innoviva Inc stock is traded at $21.09, with a volume of 155.53K. It is up +0.11% in the last 24 hours and down -1.62% over the past month. Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Previous Close:

$21.07

Open:

$21.07

24h Volume:

155.53K

Relative Volume:

0.19

Market Cap:

$1.52B

Revenue:

$434.49M

Net Income/Loss:

$504.34M

P/E Ratio:

3.5069

EPS:

6.0138

Net Cash Flow:

$181.97M

1W Performance:

+0.63%

1M Performance:

-1.62%

6M Performance:

-9.94%

1Y Performance:

+4.65%

1-Day Range:

$20.89

$21.10

1-Week Range:

$20.87

$21.70

52-Week Range:

$16.52

$25.14

Innoviva Inc Stock (INVA) Company Profile

Name

Innoviva Inc

Sector

Healthcare (1087)

Industry

Biotechnology (604)

Phone

(650) 238-9600

Address

1350 OLD BAYSHORE HIGHWAY, BURLINGAME

Employee

159

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

INVA's Discussions on Twitter

Compare INVA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INVA Innoviva Inc	21.09	1.52B	434.49M	504.34M	181.97M	6.0138
VRTX Vertex Pharmaceuticals Inc	549.38	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	826.30	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,014.91	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	138.31	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.55	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Innoviva Inc Stock (INVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-17-26	Initiated	BTIG Research	Buy
Sep-30-25	Initiated	Goldman	Sell
Aug-11-25	Initiated	Oppenheimer	Outperform
Jul-14-25	Initiated	H.C. Wainwright	Buy
Jul-11-25	Initiated	Cantor Fitzgerald	Overweight
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Jun-18-24	Initiated	Cantor Fitzgerald	Overweight
Jul-20-22	Initiated	Goldman	Neutral
Nov-20-17	Initiated	Deutsche Bank	Hold

View All

Innoviva Inc Stock (INVA) Latest News

Aug 21, 2026

Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com

Aug 21, 2026

NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat

Aug 21, 2026

Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat

Aug 21, 2026

Aug 20, 2026

Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn

Aug 20, 2026

Aug 17, 2026

70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat

Aug 17, 2026

Aug 16, 2026

Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st

Aug 16, 2026

Aug 14, 2026

Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com

Aug 14, 2026

Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat

Aug 14, 2026

Aug 13, 2026

Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn

Aug 13, 2026